The boost in phospho-AMPK. A different nutraceutical, capsaicin, has been reported to activate AMPK and improve apoptosis in HT-29 colon cancer cells (182). Bcr-abl–The Bcr-abl oncoproteins are translocation-specific gene products with the Philadelphia chromosome which might be detectable in most CML. Bcr-abl regulates proliferation, survival, differentiation, and trafficking of hematopoietic cells by transcriptional and posttranscriptional mechanisms that need tyrosine kinase activity and formation of multiprotein complexes whereby signaling molecules are assembled and activated inside the cytoplasm and inside the nucleus (183). The expression of Bcr-abl induces resistance of CML to apoptosis induced by chemotherapeutic drugs (184). Overexpression of Bcr-abl also protect against apoptotic cell death by inducing a Bcl-2 expression pathway in leukemia cells (185). Also, Bcr-abl has been shown to regulate c-jun gene expression, activation of c-Jun N-terminal kinase, and also the ras pathway, which may possibly also contribute to suppression of apoptosis, transformation, and tumorigenesis (186). Downstream mediators of Bcr-abl are recognized to regulate by the proteasome degradation. Many proteasome inhibitors for example bortezomib could suppress Bcr-abl signaling (187). Curcumin inhibits the proliferation of K562 cells and the effect is correlated with downregulation of p210bcr/abl (188). The underlying mechanism of curcumin in downregulating p210bcr/abl was identified later: It Nav1.3 Inhibitor manufacturer dissociates the binding of p210bcr/abl with Hsp90/p23 complex (189). A study carried out by William (190) showed that cur-cumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCRABL and prolongs survival of mice with acute lymphoblastic leukemia. Xhantho-humol was also reported to suppress Bcr-abl signaling. Mon-teghirofo et al. (191) showed that xanthohumol strongly inhibited Bcr-abl expression at both mRNA and protein levels. Thus, xanthohumol could induce apoptosis in all of Bcr-abl+ cells, CML cells, and clinical samples and retain its cytotoxicity in imatinib mesylate-resistant K562 cells (191). Raf/Ras–Raf is actually a member of a serine/threonine certain protein kinase loved ones and is an quick downstream target of Ras, which is implicated in the transduction of signals in the cell surface towards the nucleus (192). Within the resting cell, Ras is tightly bound to GDP. It is actually activated by binding of extracellular stimuli Topo II Inhibitor manufacturer including growth components, RTKs, T-cell receptors, and phorbol-12 myristate-13 acetate (PMA) to cell membrane receptors. Activated Ras interacts especially with effector proteins, thereby initiating cascades of protein rotein interactions that could lastly lead to regulation of cell proliferation, apoptosis, migration, fate specification, and differentiation (193). Ras also can activate a number of signaling pathways, for example Raf/MEK/ERK (extracellular signal-regulated kinases) pathway, the MEKK/SEK/JNK pathway, a PI3K/Akt/NF-B pathway, a p120-GAP/p190-B/Rac/NF-B pathway, and also a Raf/MEKK1/inhibitor-B kinase (IKK)/NF-B pathway (194). Among the spicy nutraceuticals, curcumin showed robust inhibition on Ras and Ras-related pathways. Curcumin modulates the Ras signal transduction pathway and inhibits the proliferation of K562 cells (188). Limtrakul et al. (195) showed that orally consumedNIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author ManuscriptNutr Cancer. Author manuscript; out there in PMC 2013 May possibly 06.Sung et al.Pagecurcumin (0.